• Skip to main content
  • Skip to footer

PeDRA

Pediatric Dermatology Research Alliance

  • Pay 2021 Membership Dues
  • Our Membership
  • Login
MENUMENU
  • Contact Us
  • For Patients & Families
        • Patient Support
        • Patient Education
        • Find a Pediatric Dermatologist (from SPD)
        • Clinical Trials
        • Patient Advisory Committee
        • Learn more

          about PeDRA’s efforts to build capacity for patient engagement in pediatric dermatology research.

           

  • Education and Events
        • Virtual Education
        • Early Investigator Support
        • PeDRA Podcasts
        • Mentorship Program
        • Upcoming Events
        • 2021 PeDRA Annual Conference
        • Past PeDRA Conferences
        • Education and Events Archive
        • Save the Date!

          The 2021 PeDRA Annual Conference will take place October 14-15, 2021.

           

  • Research
        • Grants & Awards
        • Studies
        • Focused Study Groups
        • Publications
        • Clinical Trials
        • Apply Now

          for the 2021 Childhood Eczema Challenge Grant being run in partnership with the National Eczema Association. Deadline to apply is May 4.

  • About
        • Mission & Vision
        • Leadership & Staff
        • Annual Reports
        • News Archive
        • Our Supporters
        • Our Membership
        • Our Committees
        • Getting to Know You
        • NOW HIRING!

          PeDRA is now hiring for a PeDRA Fellow to support organizational activities for the 2021-22 academic year (July 1, 2021 – June 30, 2022).

  • Member Login

Pediatric Dermatology COVID-19 Response Task Force Releases Guidance on Use of Systemic Immunosuppressive Therapy

April 24, 2020 By Mike Siegel

April 22, 2020 – Under the direction of Kelly Cordoro, MD of the University of California, San Francisco the Pediatric Dermatology COVID-19 Response Task Force (PDCRTF) has published a guidance manuscript on the use of systemic immunosuppressive therapies for inflammatory skin diseases in children.  Available on-line in the journal Pediatric Dermatology, the manuscript presents consensus-based recommendations assembled using a survey that completed by 37 experts in the field.    

With this manuscript, the PDCRTF addresses a variety of clinical scenarios, including treatment of patients with no symptoms, upper-respiratory infections without a COVID-19 diagnosis, confirmed COVID-19 exposure, and confirmed COVID-19 diagnoses. It is hoped that the paper can help inform health care providers and families making decisions to initiate or continue use of systemic oral and biologic medications for the treatment of inflammatory skin diseases in children including psoriasis, atopic dermatitis, and alopecia areata.  It also addresses issues facing front-line health care providers like lab monitoring and methods of communicating with patients and families. 

Visit the COVID-19 Information Page for other resources to support pediatric dermatologists, patients, and families during the COVID-19 pandemic.  Explore the PeDRA Publication Page for more on each of PeDRA’s peer-reviewed publications.    

Filed Under: News

Footer

  • Our Membership
  • For Patients
  • For Researchers
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
Sign up to receive emails from PeDRA
Join PeDRA
Donate

Copyright © 2021 · Pediatric Dermatology Research Alliance (PeDRA) · All Rights Reserved. · Privacy Policy